Diffuse Scleroderma
4 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| A Study to Evaluate the Safety and Tolerability of Oral Ixazomib in Scleroderma-related Lung Disease Patients (NCT04837131) | Michael M. Pham | 2021-04-28 |
| A Non-Interventional Pilot Study Assessing Whether Lysyl Oxidase-like 2 (LOXL2) is Present in Subjects With Scleroderma (NCT01881529) | Gilead Sciences | 2013-04-01 |
| IVIG Treatment in Systemic Sclerosis (NCT01785056) | Georgetown University | 2013-04-01 |
| IL1-TRAP, Rilonacept, in Systemic Sclerosis (NCT01538719) | Boston University | 2011-12-01 |
Track Diffuse Scleroderma automatically
Every clearance here is in the API, with alerts when new ones post.